News Uniklinik RWTH Aachen
Researchers at the Uniklinik RWTH Aachen Discover Innovative Therapeutic Approach for Treating Kidney Fibrosis and Heart Failure
A research team led by Prof. Dr. med. Rafael Kramann, Director of the Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Diseases (Medical Clinic II) has made significant…
Taster day on heart-kidney diseases: Uniklinik RWTH Aachen promotes pupils' interest in science (Kopie 1)
On 28 September, the Collaborative Research Centre TRR219 of the Institute of Molecular Cardiovascular Research (IMCAR), headed by Univ.-Prof. Dr. rer. nat. Joachim Jankowski, organised a varied…
New method for researching autosomal dominant polycystic kidney disease
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common genetic diseases in the world and affects approximately 10% of all dialysis patients. Affected patients are usually aware…
A comprehensive characterization of liver involvement in alpha1-antitrypsin deficiency published in "Gastroenterology”
The Aachen Alpha1-team around Priv.-Doz. Dr. Pavel Strnad and Dr. Karim Hamesch, who coordinate the European Reference Center for Alpha1-antitrypsin deficiency-related liver disease at the Clinic for…
Twofold distinction for the Europe-wide registry on alpha1-antitrypsin deficiency-related liver disease
Alpha1-antitrypsin deficiency (AAT deficiency) is a frequently overlooked metabolic disorder. Apart from lung disease, AAT deficiency leads to liver disease in up to 50% of patients. Although…
